Charles Cooper

Charles Cooper is a Clinical Research Fellow at the Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London. He is affiliated with the Translational Neuroscience & Psychiatry Lab led by Professor Sagnik Bhattacharyya. Currently, he works at South London and Maudsley NHS Foundation Trust as a core psychiatry trainee.

Education:

• BSc (Hons) in Molecular Biology, Cardiff University
• MBBS (Postgraduate Medical Training), University of East Anglia
• MSc in Psychiatric Research, IoPPN, King’s College London

Research Focus: Charles investigates translational approaches to improve clinical practice in psychosis. His work emphasizes neurobiological mechanisms underlying psychotic disorders and novel treatments, such as oral cannabidiol for individuals at clinical high risk for psychosis. He also explores risk factors for psychotic relapse.

Awards:

• Sir Robin Murray Prize for Academic Excellence
• Professor Shitij Kapur Prize for Innovation

Current Projects: Leading a trial on cannabidiol efficacy and studying relapse risk factors. Collaborates with the Translational Neuroscience & Psychiatry Lab and the Department of Psychosis Studies.